PEBP1 and neoplasm: Moreover, we could demonstrate that RKIP indeed regulates the RAS-MAPK/ERK pathway in these cells, which suggests that the anti-tumor effects of RKIP in myelopoiesis are mediated via the inhibition of this signaling cascade.